| Affiliation: | 1.Department of Obstetrics and Gynecology, Fryderyk Chopin University Hospital No 1,Faculty of Medicine of Rzeszow University,Rzeszów,Poland;2.Subcarpatian Oncological Hospital, Genetic Counseling Center,Brzozów,Poland;3.Department of Oncological Surgery,Regional Oncology Center,Kraków,Poland;4.Deptartment of Gynecology and Obstetetrics, Medical College,Jagiellonian University,Krakow,Poland;5.Department of Genetics and Pathology, International Hereditary Cancer Center,Pomeranian Medical University,Szczecin,Poland;6.Women’s College Research Institute,Toronto,Canada |
| Abstract: | BackgroundCausative variants in BRCA1 and BRCA2 are well-established risk factors for breast and ovarian cancer. In Poland, the causative founder variants in the BRCA1 are responsible for a significant proportion of ovarian cancer cases, however, regional differences in the frequencies of various mutations may exist. The spectrum and frequency of BRCA1/2 mutations between ovarian cancer patients have not yet been studied in the region of South-East Poland.MethodsWe examined 158 consecutive unselected cases of ovarian cancer patients from the region of Podkarpacie. We studied 13 Polish causative founder variants in BRCA1 (c.5266dupC, c.4035delA, c.5251C?>?T, c.181 T?>?G, c.676delT, c.68_69delAG, c.3700_3704delGTAAA, c.1687C?>?T, c.3756_3759delGTCT) and in BRCA2 (c.658_659delGT, c.7910_7914delCCTTT, c.3847_3848delGT, c.5946delT).ResultsA BRCA1 causative founder variants were detected in 10 of the 158 (6.3%) ovarian cancer cases. BRCA2 causative founder variants were not observed. The c.5266dupC mutation was detected in 6 patients, c.181 T?>?G mutation in 3 patients and the c.676delT mutation in 1 patient. The median age of diagnosis of the 10 hereditary ovarian cancers was 55.5 years of age.ConclusionsThe frequency of 13 causative founder variants in Podkarpacie was lower than in other regions of Poland. Testing of three BRCA1 mutations (c.5266dupC, c.181 T?>?G, c.676delT) should be considered a sensitive test panel. |
